Palvella Therapeutics PVLA
NASDAQ PVLA
$126.58 +2.66 (+2.15%)
At close: Oct 21, 2026 · 4:00 PM EDT

Palvella Therapeutics (PVLA) Interest Paid (2014 - 2015)

Updated

Analysis

Palvella Therapeutics (PVLA) Interest Paid (2014 - 2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Paid (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 339.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 1.07 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 1.25 Bn
10 Palvella Therapeutics 1.82 Bn 1.57 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 202,088.00
Sep 30, 2015 -43.00
Mar 31, 2015 4,224.00
Mar 31, 2014 27,059.00
API Access

Palvella Therapeutics Interest Paid API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-paid&ticker=PVLA&period=max&api_key=YOUR_API_KEY